lncRNA UCA1-Mediated Cdc42 Signaling Promotes Oncolytic Vaccinia Virus Cell-to-Cell Spread in Ovarian Cancer

Oncolytic vaccinia virus (OVV) has demonstrated appropriate safety profiles for clinical development. Although designed to kill cancer cells efficiently, OVV sensitivity varies in individual cancers, and predictive biomarkers of therapeutic responses have not been identified. Here we found that OVV...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Ther Oncolytics
Main Authors: Horita, Kosuke, Kurosaki, Hajime, Nakatake, Motomu, Kuwano, Nozomi, Oishi, Tetsuro, Itamochi, Hiroaki, Sato, Sho, Kono, Hiromichi, Ito, Mai, Hasegawa, Kosei, Harada, Tasuku, Nakamura, Takafumi
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Gene & Cell Therapy 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6463205/
https://ncbi.nlm.nih.gov/pubmed/31011626
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omto.2019.03.003
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados